clinical study to evaluate effect of shunthyadi kwath in mutrashmari w.s.r to urolithiasis

An open randomised controlled clinical trial to evaluate efficacy of shunthyadi kwath in mutrashmari w.s.r to urolithiasis - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090911

Enrollment

Registered

2025-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of either sex. 2. Age between 20 - 60 yrs. 3. Patient of Mutrashmariwith USG evidence of single calculus/multiple calculi of 4 mm to max 10 mm. 4. Patient of Mutrashmari with renal, uretric, and UVJ calculus.

Exclusion criteria

Exclusion criteria: 1. Patients of obstructive pathology with changes of severe hydronephrosis in USG. 2. Patient is having uncontrolled diabetes, Asthma and other major systemic illness. 3. Impaired renal function. 4. Pregnant and lactating mother. 5. Urinary calculi having size more than 10 mm. 6. Kshar ayogya vyadhi like Jwara, Raktapitta, Urahkshat, Murchha, UTI.

Design outcomes

Primary

Measure	Time frame
1.To compare the efficacy of Shunthyadikwath with Varunadikwath in the management of Mutrashmari. Timepoint: 45 days	—

Secondary

Measure	Time frame
1. To find out whether this drug reduces the size of Mutrashmari or promotes its expulsion. 2. To find out its effect on the symptoms of Mutrashmarilike burning micturition,pain hematuria etc. Timepoint: 45 days	—

Countries

India

Contacts

Public ContactVidya Murlidhar Jangle

R.A.podar govt. ayurved college Worli mumbai

vidyajangle@gmail.com8698681417

Outcome results